missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human TNF-alpha Recombinant Protein
Recombinant Human Tumor Necrosis Factor-α (TNF) is a bioactive protein intended for use in cell culture applications
Brand: Gibco™ PHC3016
This item is not returnable.
View return policy
Description
Human TNF-alpha Recombinant Protein for Western Blot, IHC, ELISA, Ctrl, FN
TNF causes cytolysis and cytostasis of many tumor cell lines. TNF has a wide spectrum of activities, including chemotaxis of neutrophils, alteration of the endothelium, inhibition of anticoagulatory mechanisms, and promotion of angiogenesis.- High purity: no interference from other proteins or contaminants
- High biological activity: more results with less protein
- Proven compatibility: Gibco proteins bioassayed with Gibco media
- High Purity Recombinant Bioactive Protein: to help ensure Gibco growth factors are of the highest quality, each protein is analyzed for purity along with structural homogeneity to ensure a biologically active protein
- High Biological Activity: in-house activity testing of Gibco Recombinant Proteins includes cell proliferation, cytotoxicity, chemotaxis, calcium flux, secondary cytokine up-regulation, induction of surface antigen expression, anti-viral, and protease assays; specific activity is determined by the dose dependent cytotoxic effect on L929 cells in the presence of actinomycin D
- Proven Compatibility: Gibco proteins are bioassayed with Gibco media
Shipping Condition: Wet Ice.
Specifications
| Cell Culture | |
| 17.5 kDa | |
| 50 μg | |
| Human | |
| Carrier-Free | |
| 50 μg | |
| E. coli | |
| Recombinant, Ligand | |
| TNF (Tumor Necrosis Factor) | |
| Gibco™ |
| 7124 | |
| Sequential Chromatography | |
| TNF-α | |
| Store in refrigerator (2–8°C). | |
| < 0.1 ng/μg | |
| Wet Ice | |
| Cytokines & Receptors | |
| Lyophilized | |
| Immunology, Signal Transduction, Stem Cell Research, Inflammation, Oncology | |
| 95 % |
For Research Use Only. Not intended for animal or human diagnostic or therapeutic use.